Pathstone Holdings »

Pmv Pharmaceuticals shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $25k 18k 1.40
2025-06-30 $19k 18k 1.06

More positions owned by Pathstone Holdings

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Crowdstrike Hldgs Cl A (CRWD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
BML Capital Management
Tang Capital Management
Arrowpoint Asset Management
Sio Capital Management
Euclidean Capital
Vanguard Group
Acadian Asset Management
Stonepine Capital Management
BlackRock
Marshall Wace
Aldebaran Capital
Geode Capital Management
Two Sigma Advisers
Jane Street

View all funds holding Pmv Pharmaceuticals